IDEAYA Biosciences (IDYA) News Today $24.91 -0.09 (-0.36%) Closing price 03:59 PM EasternExtended Trading$24.91 0.00 (0.00%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Vanguard Group Inc. Purchases 14,535 Shares of IDEAYA Biosciences, Inc. $IDYAAugust 26 at 3:04 AM | marketbeat.comIDEAYA Biosciences to Participate in Upcoming September 2025 Investor Relations EventsAugust 25 at 6:00 AM | prnewswire.comCandriam S.C.A. Trims Stock Position in IDEAYA Biosciences, Inc. $IDYAAugust 23, 2025 | marketbeat.comAberdeen Group plc Boosts Stock Holdings in IDEAYA Biosciences, Inc. $IDYAAugust 23, 2025 | marketbeat.comAlgert Global LLC Acquires Shares of 306,708 IDEAYA Biosciences, Inc. $IDYAAugust 21, 2025 | marketbeat.comIDEAYA Biosciences Announces Agenda for 10-Year Anniversary R&D Day on September 8, 2025August 18, 2025 | prnewswire.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Deutsche Bank AGAugust 17, 2025 | marketbeat.comRBC Capital Remains a Buy on IDEAYA Biosciences (IDYA)August 11, 2025 | theglobeandmail.comLeerink Partnrs Has Bullish Estimate for IDYA Q3 EarningsAugust 11, 2025 | marketbeat.comFY2025 EPS Estimates for IDYA Cut by Cantor FitzgeraldAugust 9, 2025 | marketbeat.comXTX Topco Ltd Acquires 17,536 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)August 9, 2025 | marketbeat.comQ3 EPS Forecast for IDEAYA Biosciences Increased by AnalystAugust 8, 2025 | marketbeat.comGSK and Ideaya’s Promising Study on Tumor-Reducing Drug GSK4418959August 7, 2025 | msn.comIDEAYA Biosciences (NASDAQ:IDYA) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPSAugust 6, 2025 | marketbeat.comIdeaya Biosciences: Moving Into ADCs For Solid TumorsAugust 6, 2025 | seekingalpha.comIDEAYA (IDYA) Q2 Net Loss Improves 27%August 5, 2025 | fool.comIDEAYA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 5, 2025 | prnewswire.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of "Moderate Buy" by AnalystsAugust 5, 2025 | marketbeat.comTD Asset Management Inc Sells 30,254 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)August 5, 2025 | marketbeat.comBIT Capital GmbH Cuts Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)August 4, 2025 | marketbeat.comVictory Capital Management Inc. Sells 297,763 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)August 3, 2025 | marketbeat.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | prnewswire.comIDEAYA Biosciences (IDYA) Projected to Post Earnings on TuesdayJuly 30, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Sold by Federated Hermes Inc.July 30, 2025 | marketbeat.comFiera Capital Corp Grows Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)July 30, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysJuly 28, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Trading Up 6.6% - Here's What HappenedJuly 25, 2025 | marketbeat.comTD Cowen Bullish on Ideaya’s (IDYA) Oncology PipelineJuly 25, 2025 | msn.comIDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal MelanomaJuly 24, 2025 | prnewswire.comIdeaya Biosciences, Hengrui announce oral presentation at IASLC 2025July 23, 2025 | msn.comTD Cowen Initiates Coverage of IDEAYA Biosciences (IDYA) with Buy RecommendationJuly 23, 2025 | msn.comIDEAYA Biosciences Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth StrategyJuly 23, 2025 | prnewswire.comIDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADCJuly 22, 2025 | prnewswire.comIDEAYA Biosciences (NASDAQ:IDYA) Coverage Initiated by Analysts at TD CowenJuly 22, 2025 | marketbeat.comIDEAYA Biosciences to Participate in Upcoming July 2025 Investor Relations EventJuly 21, 2025 | prnewswire.comJennison Associates LLC Trims Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)July 21, 2025 | marketbeat.comGeneral American Investors Co. Inc. Increases Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)July 17, 2025 | marketbeat.comIDEAYA Biosciences (IDYA) Receives a Hold from Goldman SachsJuly 12, 2025 | theglobeandmail.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Recommendation of "Moderate Buy" by BrokeragesJuly 11, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Earns Neutral Rating from Analysts at The Goldman Sachs GroupJuly 10, 2025 | marketbeat.comIDYA - IDEAYA Biosciences Inc Financials - MorningstarJuly 9, 2025 | morningstar.comMIdeaya Biosciences price target lowered to $30 from $57 at RBC CapitalJuly 9, 2025 | msn.comIDEAYA Biosciences (NASDAQ:IDYA) Price Target Lowered to $30.00 at Royal Bank Of CanadaJuly 9, 2025 | marketbeat.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)June 27, 2025 | prnewswire.comIDEAYA Biosciences (NASDAQ:IDYA) Rating Increased to Strong-Buy at Wells Fargo & CompanyJune 27, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Stock, Short Interest ReportJune 27, 2025 | benzinga.comWells Fargo Initiates Coverage of IDEAYA Biosciences (IDYA) with Overweight RecommendationJune 27, 2025 | msn.comIDEAYA Biosciences (NASDAQ:IDYA) Stock, Insider Trading ActivityJune 26, 2025 | benzinga.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of "Moderate Buy" from BrokeragesJune 16, 2025 | marketbeat.comHere's Why Steve Cohen's Point72 Recently Shelled Out Over $100M for Two Biopharma StocksJune 10, 2025 | msn.com Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDYA Media Mentions By Week IDYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDYA News Sentiment▼1.530.99▲Average Medical News Sentiment IDYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDYA Articles This Week▼56▲IDYA Articles Average Week Get the Latest News and Ratings for IDYA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IDEAYA Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Verona Pharma PLC American Depositary Share News Roivant Sciences News Grifols News Revolution Medicines News Rhythm Pharmaceuticals News Legend Biotech News Avidity Biosciences News Axsome Therapeutics News Abivax News Nuvalent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDYA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access